Related Experiment Video

Updated: Oct 5, 2025

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.4K

Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential

Ji-Zheng Tian1, Ni-Na Ma1, Xiao Li1

  • 1Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Neoplasma
|February 1, 2022
PubMed

Insights

New therapeutic strategies are needed for bone metastasis, as current treatments like bisphosphonates and denosumab are ineffective for some patients and do not improve survival. This review explores bone metastasis mechanisms and potential drug targets.

Area of Science:

  • Oncology
  • Orthopedics
  • Pharmacology

Background:

  • Bone is a frequent site for cancer metastasis due to complex tumor cell-bone microenvironment interactions.
  • Current treatments, bisphosphonates and denosumab, primarily prevent skeletal-related events but do not improve overall survival in bone metastasis patients.
  • There is a critical need for novel bone-modifying agents and therapeutic strategies to address the limitations of existing treatments.

Purpose of the Study:

  • To review the fundamental mechanisms of bone metastasis.
  • To emphasize the development of fundamental and potential target drugs for bone metastasis.
  • To provide insights into new and effective treatment strategies by summarizing drug development processes.

Main Methods:

  • Literature review of bone metastasis mechanisms.
  • Analysis of current therapeutic strategies and their limitations.
  • Exploration of potential drug targets and development pathways.

Main Results:

  • Bone metastasis involves intricate interactions within the bone microenvironment.
  • Approved therapies offer limited efficacy and do not enhance overall survival.
  • Numerous targets exist for developing novel therapeutic agents.

Conclusions:

  • Effective treatments for bone metastasis require addressing its complex biological mechanisms.
  • Further research into novel bone-modifying agents and drug targets is essential.
  • Developing new therapies holds promise for improving patient outcomes and overall survival.

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

5.6K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
711
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K